Corticosteroid-binding globulin and unbound serum cortisol in women with polycystic ovary syndrome

Clinical Biochemistry

Volumn 33, Issue 2, 2000, Pages 157-159

  Vogeser, Michael ^a   Halser, Brigitte ^a   Baron, Anne ^a   Jacob, Karl ^a   Demant, Thomas ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; TRANSCORTIN;

ADULT; ANALYTICAL EQUIPMENT; ARTICLE; BODY MASS; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FEMALE INFERTILITY; HORMONE BINDING; HORMONE DETERMINATION; HUMAN; HYPERANDROGENISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL;

ADULT; AGE FACTORS; BIOLOGICAL MARKERS; BODY CONSTITUTION; BODY MASS INDEX; FEMALE; HUMANS; HYDROCORTISONE; POLYCYSTIC OVARY SYNDROME; REFERENCE VALUES; TESTOSTERONE; TRANSCORTIN;

EID: 0033999241     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(00)00051-5     Document Type: Article

References (14)

1. Carmina E., Lobo R.A. Polycystic ovary syndrome (PCOS) arguably the most common endocrinopathy is associated with significant morbitiy in women . J Clin Endocrinol Metab. 84:1999;1897-1899.
2. Rosenfield R.L. Ovarian and adrenal function in polycystic ovary syndrome. Endocrinol Metabol Clin North Am. 28:1999;265-293.
3. Gennarelli G., Holte J., Strindsberg M., et al. Response of the pituitary-adrenal axis to hypoglycemic stress in women with the polycystic ovary syndrome. Clin Endocrinol Metab. 84:1999;76-81.
4. Rodin A., Thakkar H., Taylor N., Clayton R. Hyperandrogenism in polycystic ovary syondrome - evidence of dysregulation of the 11β-hydroxysteroid dehydrogenase. N Engl J Med. 330:1994;460-465.
5. Luppa P., Müller B., Jacob K., et al. Variations of steroid hormone metabolites in serum and urine in polycystic ovary syndrome after nafarelin stimulation evidence for an altered corticoid excretion . J Clin Endocrinol Metab. 80:1995;280-288.
6. Invitti C., Giraldi F.P., Dubini A., De Martin M., Cavagnini F. Increased urinary free cortisol and decreased serum corticosteroid-binding globulin in polycystic ovary syndrome. Acta Endocrinol. 125:1991;28-32.
7. Heyns W., Coolens J.L. Physiology of corticosteroid-binding globulin in humans. Ann N Y Acad Sci. 538:1988;122-129.
8. Tsigos C., Kyrou I., Chrousos G.P., Papanicolaou D.A. Prolonged suppression of corticosteroid-binding globulin by recombinant human interleukin-6 in man. J Clin Endocrinol Metab. 83:1998;3379-3382.
9. Vogeser M., Felbinger T.W., Kilger E., Röll W., Fraunberger P., Jacob K. Corticosteroid-binding globulin and free cortisol in the early postoperative period after cardiac surgery. Clin Biochem. 32:1999;213-216.
10. Coolens J.L., Van Baelen H., Heyns W. Clinical use of unbound plasma cortisol as calculated from total cortisol and corticosteroid-binding globulin. J Steroid Biochem. 26:1987;197-202.
11. Dickinson P., Zinneman H.H., Swaim W.R., Doe R.P., Seal U.S. Effects of testosterone treatment on plasma protein and amino acids in men. J Clin Endocrinol Metab. 29:1969;837-841.
12. Hammond GL, Smith CL, Goping IS, et al. Primary structure of human corticosteroid binding globulin, deduced from hepatic and pulmonary cDNAs, exhibits homology with serine protease inhibitors. Proc Natl Acad Sci USA 1987; 84: 5153-17.
13. Pemberton P.A., Stein P.E., Pepys M.B., Potter J.M., Carrell R.W. Hormone binding globulins undergo serpin conformational change in inflammation. Nature. 336:1988;257-258.
14. Hryb D.J., Khan M.S., Romas N.A., et al. Specific binding of human corticosteroid-binding globulin to cell membranes. Proc Natl Acad Sci USA. 83:1986;3253-3258.